Blaise Coleman

Blaise Coleman is Executive Vice President and Chief Financial Officer for Endo International , Inc.(ENDPQ) plc, a leading global specialty pharmaceutical company. Blaise joined Endo in January 2015 as its Senior Vice President, Global Finance Operations. Prior to joining Endo, Blaise held a number of finance leadership roles with AstraZeneca, a global biopharmaceutical company, latterly as the Chief Financial Officer of the AstraZeneca / Bristol-Myers Squibb U.S. Diabetes Alliance. Prior to this, Blaise was the Head of Finance for the AstraZeneca global medicines development organization based in Mölndal, Sweden from September 2011 to January 2013. Blaise joined AstraZeneca as Senior Director, Commercial Finance for the U.S. cardiovascular business in November 2007.

Blaise joined AstraZeneca from Centocor, a wholly owned subsidiary of Johnson & Johnson, where he held positions in the respective Licenses & Acquisitions and Commercial Finance organizations. Blaise's move to Centocor in early 2003 followed 7 years' experience with the global public accounting firm PricewaterhouseCoopers LLP, latterly as a manager in the Global Pharmaceutical Assurance practice.

Blaise is a Certified Public Accountant and obtained a Six Sigma - Process Excellence Green Belt certification while at Johnson & Johnson. He has an accounting degree from Widener University and an MBA from Duke University’s Fuqua School of Business. Blaise is married with three children and currently resides in Malvern, Pennsylvania.